GSK IP chief welcomes "balanced" European Competition DG pharma report

As we commented on this blog last week, the European Commission Competition DG report into the use of intellectual property in the pharmaceutical sector was not as bad as many (including us) were fearing it would be. In the next issue of IAM, which…

Get unlimited access to all IAM content